-Mien-Chie Hung Researcher Activity Profile

Research Author Detailed Information 

Mien-Chie Hung Publication Rate By Year

Mien-Chie Hung has published 2 paper(s) in 2005, 4 paper(s) in 2006, 24 paper(s) in 2007, 10 paper(s) in 2008, for a total of 40 research publications in total.

Mien-Chie Mc Hung Author Information

LAST NAME: hung

FIRST NAME: Mien-Chie

INITIALS: mc

AFFILIATION:

Papers

Mien-Chie Hung's Publication Record

1. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Year Published: 2007
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei 10018, Taiwan; Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
2. Molecular mechanisms in Barrett's metaplasia and its progression. Year Published: 2007
Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. jizzo@mdanderson.org
3. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
4. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Year Published: 2007
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
5. Signaling intricacies take center stage in cancer cells. Year Published: 2005
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. rkumar@mdanderson.org
6. Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer. Year Published: 2006
Department of Molecular and Cellular Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.
7. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. Year Published: 2006
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA.
8. Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers. Year Published: 2006
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
9. Tyrosine phosphorylation controls PCNA function through protein stability. Year Published: 2006
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
10. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. Year Published: 2007
Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
11. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
12. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, Usa.
13. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
14. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
15. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents. Year Published: 2007
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
16. Rapamycin regulates the phosphorylation of rictor. Year Published: 2007
Department of Surgical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030, USA.
17. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Year Published: 2007
Department of Surgery, The Comprehensive Cancer Center, Duke University, Durham, North Carolina, USA.
18. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Year Published: 2007
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
19. Novel approaches for chemosensitization of breast cancer cells: the E1A story. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
20. Breast cancer brain metastases. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
21. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Year Published: 2007
1Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
22. Novel approaches for chemosensitization of breast cancer cells: the E1A story. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
23. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Year Published: 2007
Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
24. Breast cancer brain metastases. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
25. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Year Published: 2007
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
26. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents. Year Published: 2007
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
27. All Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis. Year Published: 2008
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA.
28. GSK-3beta Targets Cdc25A for Ubiquitin-Mediated Proteolysis, and GSK-3beta Inactivation Correlates with Cdc25A Overproduction in Human Cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
29. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Year Published: 2007
Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
30. Breast cancer brain metastases. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
31. Lenticular subluxation in a patient with homocystinuria undetected by neonatal screening. Year Published: 2008
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
32. All Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis. Year Published: 2008
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA.
33. Fine tuning the purity of blue emission from polydioctylfluorene by end-capping with electron-deficient moieties. Year Published: 2005
Chemical Engineering Department, National Tsing-Hua University, Hsinchu 30041, Taiwan, Republic of China.
34. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Year Published: 2008
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
35. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA.
36. The Role of Eosinophil Cationic Protein in Patients with Mycoplasma pneumoniae Infection. Year Published: 2008
Department of Pediatrics, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
37. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Year Published: 2008
Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
38. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Year Published: 2008
Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110, USA.
39. Lenticular subluxation in a patient with homocystinuria undetected by neonatal screening. Year Published: 2008
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, R O C.
40. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Year Published: 2007
Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.